| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 30 |
| 1 | MEPOLIZUMAB | 25 |
| 2 | ACETAMINOPHEN | 23 |
| 3 | ALBUTEROL SULFATE | 23 |
| 4 | BISOPROLOL FUMARATE | 23 |
| 5 | DIAZEPAM | 23 |
| 6 | DIAZEPAM ORAL | 23 |
| 7 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 23 |
| 8 | ESCITALOPRAM | 23 |
| 9 | ESCITALOPRAM OXALATE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RABEPRAZOLE SODIUM | 21 | 0.0008 |
| 1 | ROSUVASTATIN CALCIUM | 21 | 0.0007 |
| 2 | ALENDRONATE SODIUM TABLET | 12 | 0.0006 |
| 3 | MEPOLIZUMAB | 25 | 0.0005 |
| 4 | MELOXICAM | 23 | 0.0004 |
| 5 | OMALIZUMAB | 23 | 0.0003 |
| 6 | DIAZEPAM ORAL | 23 | 0.0003 |
| 7 | ALENDRONATE SODIUM | 21 | 0.0002 |
| 8 | DIAZEPAM | 23 | 0.0002 |
| 9 | MONTELUKAST SODIUM | 23 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 30 |
| 1 | Interleukin-5 Antagonist [EPC] | 25 |
| 2 | Aldosterone Antagonist [EPC] | 24 |
| 3 | Loop Diuretic [EPC] | 24 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 5 | Anti-IgE [EPC] | 23 |
| 6 | Benzodiazepine [EPC] | 23 |
| 7 | Expectorant [EPC] | 22 |
| 8 | Leukotriene Receptor Antagonist [EPC] | 3 |
| 9 | Platinum-based Drug [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 25 | 0.0363 |
| 1 | Anti-IgE [EPC] | 23 | 0.0003 |
| 2 | Aldosterone Antagonist [EPC] | 24 | 0.0002 |
| 3 | Expectorant [EPC] | 22 | 0.0001 |
| 4 | Leukotriene Receptor Antagonist [EPC] | 3 | 0.0001 |
| 5 | Loop Diuretic [EPC] | 24 | 0.0001 |
| 6 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 7 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | Benzodiazepine [EPC] | 23 | 0.0000 |